Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07787949

Injectable Platelet-Rich Fibrin With Minimally Invasive Non-Surgical Technique in Treatment of Grade II Furcation Defects

This study aims to compare the clinical and radiographic effectiveness of injectable platelet-rich fibrin (i-PRF) combined with minimally invasive non-surgical therapy (MINST) versus MINST alone in the management of class II furcation defects.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

October 6 University (Faculty of Dentistry)

Giza, Giza Governorate, 12511, Egypt

Location status: Recruiting

Location contact

Moustafa A Ahmed, B.D.S

CONTACT

[email protected]

00201098378998

Reham L Aggour, MD

SUB_INVESTIGATOR

Shereen F Ahmed, MD

SUB_INVESTIGATOR

Wessam I Shehab, MD

SUB_INVESTIGATOR

About this study

Periodontitis is a multifactorial inflammatory disease that occurs due to the challenge between the host response and specific periodontal pathogens, leading to a gradual destruction of the periodontal supporting tissues over time.

Different regenerative approaches have been proposed including guided tissue regeneration (GTR); bone grafts, bioactive agents such as enamel matrix derivative (EMD) and platelet concentrates.

Using the minimally invasive nonsurgical technique (MINST) implements magnification with microscope/loupes and delicate instruments, to perform the periodontal debridement with more effective root debridement and less soft tissue trauma. MINST significantly improve the visualization and root decontamination, and at the same time preserve the gingival margin and consequently improve the aesthetic results and tissue stability.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients of both genders >18 years old, medically free of systemic diseases affecting periodontal regeneration.
  • Diagnosis of stage III, grade B periodontitis (according to the AAP/EFP classification 2018) with the presence of class II furcation defect in either the maxillary (buccal) or mandibular arch (buccal or lingual) as determined by clinical evaluation and confirmed by radiographic evaluation.
  • Gingival margin and interdental bone positioned coronally to the furcation entrance.
  • Commitment to maintenance visits and follow-up.
  • Absence of primary endodontic lesions.

Exclusion criteria

  • Patients suffering from any systemic diseases that may affect the outcome of periodontal therapy, including diabetes, immune deficiencies, etc;
  • Patients that received periodontal surgical treatments in the past 12 months.
  • Smoking (current or in past 5 years)
  • Prolonged treatment with antibiotics or anti-inflammatory agents within 6 months prior to periodontal therapy.
  • Pregnant and lactating females.
  • Teeth with hopeless prognosis
  • Third molars

Treatment and study plan

Minimally invasive non-surgical technique (MINST)

Procedure

Patients will receive minimally invasive non-surgical technique (MINST) alone

Minimally invasive non-surgical technique (MINST) + injectable platelet-rich fibrin (i-PRF) injection

Procedure

Patients will receive minimally invasive non-surgical technique (MINST) + injectable platelet-rich fibrin (i-PRF) injection

Primary outcomes

  1. Change in Radiographic Bone Fill at the Furcation Site

    Time frame: 6 months after treatment

    Radiographic bone fill at the furcation site will be assessed using cone-beam computed tomography (CBCT). The analysis will include measurement of the filled bone volume (FBV) at the furcation area using segmentation.

Secondary outcomes

  1. Change in Horizontal Clinical Attachment Level

    Time frame: 6 months after treatment

    Horizontal clinical attachment level will be assessed using periodontal probing at baseline and 6 months after treatment.

  2. Change in Vertical Clinical Attachment Level

    Time frame: 6 months after treatment

    Vertical clinical attachment levels will be assessed using periodontal probing at baseline and 6 months after treatment.

  3. Change in Probing Pocket Depth

    Time frame: 6 months after treatment

    Probing pocket depth (PPD) will be measured in millimeters from the gingival margin to the base of the periodontal sulcus at six sites per tooth using a UNC-15 periodontal probe. Measurements will be recorded at baseline and 6 months after treatment.

  4. Change in Gingival Margin Location

    Time frame: 6 months after treatment

    The location of the gingival margin will be assessed by measuring the distance from the cemento-enamel junction (CEJ) to the gingival margin. Measurements will be recorded at baseline and 6 months after treatment.

  5. Change in Plaque Index

    Time frame: 6 months after treatment

    Plaque index (PI) will be assessed to evaluate oral hygiene status by measuring dental plaque accumulation in areas adjacent to the gingival margin. Plaque index will be recorded at baseline and 6 months after treatment.

  6. Change in Bleeding on Probing

    Time frame: 6 months after treatment

    Bleeding on probing (BoP) will be assessed by gently inserting a periodontal probe into the gingival sulcus at the base of the interdental papilla and recording the intensity of bleeding after a short delay. BoP will be assessed at baseline and 6 months after treatment.

Study contacts

Contact information is provided by the study sponsor or research team.

Moustafa A Ahmed, B.D.S

CONTACT

[email protected]

00201098378998

Sponsors and collaborators

Lead sponsor

October 6 University

Other

Registry information

Official study title

Evaluation of Injectable Platelet-Rich Fibrin With Minimally Invasive Non-Surgical Technique in Treatment of Grade II Furcation Defects: A Randomized Clinical Trial

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Aug 26, 2026
Registry last updated
Aug 26, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.